These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29428729)

  • 1. Downregulated CDKN1C/p57
    Qiu Z; Li Y; Zeng B; Guan X; Li H
    Biochem Biophys Res Commun; 2018 Feb; 497(1):187-193. PubMed ID: 29428729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P21-activated kinase 4 regulates the cyclin-dependent kinase inhibitor p57(kip2) in human breast cancer.
    Li Y; Wang D; Zhang H; Wang C; Dai W; Cheng Z; Wang G; Li F
    Anat Rec (Hoboken); 2013 Oct; 296(10):1561-7. PubMed ID: 23873832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CDKN1C in the bone marrow of patients with myelodysplastic syndrome and secondary acute myeloid leukemia is associated with poor survival after conventional chemotherapy.
    Radujkovic A; Dietrich S; Andrulis M; Benner A; Longerich T; Pellagatti A; Nanda K; Giese T; Germing U; Baldus S; Boultwood J; Ho AD; Dreger P; Luft T
    Int J Cancer; 2016 Sep; 139(6):1402-13. PubMed ID: 27170453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and Epigenetic Control of CDKN1C Expression: Importance in Cell Commitment and Differentiation, Tissue Homeostasis and Human Diseases.
    Stampone E; Caldarelli I; Zullo A; Bencivenga D; Mancini FP; Della Ragione F; Borriello A
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29614816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDKN1C/P57 is regulated by the Notch target gene Hes1 and induces senescence in human hepatocellular carcinoma.
    Giovannini C; Gramantieri L; Minguzzi M; Fornari F; Chieco P; Grazi GL; Bolondi L
    Am J Pathol; 2012 Aug; 181(2):413-22. PubMed ID: 22705236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hallmarks of CDKN1C (p57, KIP2) in cancer.
    Kavanagh E; Joseph B
    Biochim Biophys Acta; 2011 Aug; 1816(1):50-6. PubMed ID: 21447370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of p27
    Kim GJ; Kim DH; Min KW; Kim YH; Oh YH
    Pathol Res Pract; 2018 Apr; 214(4):565-571. PubMed ID: 29482985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDKN1C (p57) is a direct target of EZH2 and suppressed by multiple epigenetic mechanisms in breast cancer cells.
    Yang X; Karuturi RK; Sun F; Aau M; Yu K; Shao R; Miller LD; Tan PB; Yu Q
    PLoS One; 2009; 4(4):e5011. PubMed ID: 19340297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of decorin and p57(KIP2) correlates with poor survival and lymphatic metastasis in lung cancer patients.
    Biaoxue R; Xiguang C; Hua L; Hui M; Shuanying Y; Wei Z; Wenli S; Jie D
    Int J Biol Markers; 2011; 26(1):9-21. PubMed ID: 21360479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The KIP/CIP family members p21^{Waf1/Cip1} and p57^{Kip2} as diagnostic markers for breast cancer.
    Zohny SF; Baothman OA; El-Shinawi M; Al-Malki AL; Zamzami MA; Choudhry H
    Cancer Biomark; 2017; 18(4):413-423. PubMed ID: 28106536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDKN1C as a prognostic biomarker correlated with immune infiltrates and therapeutic responses in breast cancer patients.
    Lai J; Lin X; Cao F; Mok H; Chen B; Liao N
    J Cell Mol Med; 2021 Oct; 25(19):9390-9401. PubMed ID: 34464504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.
    Fornari F; Gramantieri L; Ferracin M; Veronese A; Sabbioni S; Calin GA; Grazi GL; Giovannini C; Croce CM; Bolondi L; Negrini M
    Oncogene; 2008 Sep; 27(43):5651-61. PubMed ID: 18521080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDKN1C/p57kip2 is a candidate tumor suppressor gene in human breast cancer.
    Larson PS; Schlechter BL; King CL; Yang Q; Glass CN; Mack C; Pistey R; de Las Morenas A; Rosenberg CL
    BMC Cancer; 2008 Mar; 8():68. PubMed ID: 18325103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MicroRNA-221 controls CDKN1C/P57 expression in human colorectal carcinoma].
    Sun K; Zeng JJ; Wang W; Wu CT; Lei ST; Li GX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Apr; 14(4):279-83. PubMed ID: 21538272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of the cyclin-dependent kinase inhibitor p57 is mediated by Jab1/Csn5 in hepatocarcinogenesis.
    Guo H; Jing L; Cheng Y; Atsaves V; Lv Y; Wu T; Su R; Zhang Y; Zhang R; Liu W; Rassidakis GZ; Wei Y; Nan K; Claret FX
    Hepatology; 2016 Mar; 63(3):898-913. PubMed ID: 26606000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel long non-coding RNA FGF14-AS2 is correlated with progression and prognosis in breast cancer.
    Yang F; Liu YH; Dong SY; Ma RM; Bhandari A; Zhang XH; Wang OC
    Biochem Biophys Res Commun; 2016 Feb; 470(3):479-483. PubMed ID: 26820525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [MicroRNA-221 promotes colon carcinoma cell proliferation in vitro by inhibiting CDKN1C/p57 expression].
    Sun K; Wang W; Lei ST; Wu CT; Li GX
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1885-9. PubMed ID: 22126772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The developmental expression of the CDK inhibitor p57(kip2) (Cdkn1c) in the early mouse placenta.
    Saunders AC; McGonnigal B; Uzun A; Padbury J
    Mol Reprod Dev; 2016 May; 83(5):405-12. PubMed ID: 26988311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p57(Kip2) and cancer: time for a critical appraisal.
    Borriello A; Caldarelli I; Bencivenga D; Criscuolo M; Cucciolla V; Tramontano A; Oliva A; Perrotta S; Della Ragione F
    Mol Cancer Res; 2011 Oct; 9(10):1269-84. PubMed ID: 21816904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple mechanisms downregulate CDKN1C in human bladder cancer.
    Hoffmann MJ; Florl AR; Seifert HH; Schulz WA
    Int J Cancer; 2005 Apr; 114(3):406-13. PubMed ID: 15551363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.